Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…pivacaine group with statistical significance (p values <0.05). Liposomal bupivacaine was associated with a lower incidence of nausea.Conclusions The…
…es (3.8% vs 1.5%, p=0.444).Conclusions Perianal infiltration of liposomal bupivacaine significantly alleviates postoperative resting and exercise pai…
… limitations such as catheter displacement and infection risks. Liposomal bupivacaine, an ultra-long-acting local anaesthetic, offers prolonged analg…
…Background and Aims Liposomal bupivacaine (LB) is becoming an important drug for postoperative analgesia …
…combined with two local anaesthetic adjuncts (dexamethasone and dexmedetomidine) for postoperative pain relief in VATS patients.Methods and ana…
…. These findings suggest that single-injection SPIP blocks with liposomal bupivacaine may not be as effective as repeated injections or catheters in …
…d discharge readiness, we assessed whether formulary removal of liposomal bupivacaine impacted hospital LOS following thoracoscopic pulmonary wedge r…
…uated intraoperative intravenous lidocaine infusions (IVLI) and liposomal bupivacaine (LB) injection to optimize postoperative analgesia in pediatric…
…eous surgical population. Their conclusion, that the removal of liposomal bupivacaine did not adversely affect the length of stay (LOS) or short-term…
…ested for brachial plexus blocks include adrenaline, clonidine, dexmedetomidine, ketamine, magnesium, dexamethasone and buprenorphine. Most of …
…ponse triggered by preoperative pain are the main risk factors. Liposomal bupivacaine (LB) single-injection pericapsular nerve group (PENG) block has…
…n our recent publication examining the implications of removing liposomal bupivacaine from an academic hospital formulary.1 2 Their five itemized com…